当前位置:首页 - 行情中心 - 天康生物(002100) - 财务分析

天康生物

(002100)

  

流通市值:85.60亿  总市值:85.60亿
流通股本:13.65亿   总股本:13.65亿

天康生物(002100)财务分析

净利润 + 每股收益
Created with Highcharts 9.1.009-3006-3003-3112-31-32-16016-1.2-0.600.6
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润5.54亿元,每股收益0.41元。

股东权益 + 未分配利润
Created with Highcharts 9.1.009-3006-3003-3112-310306090481216
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益848041.26万元,未分配利润111274.15万元。

总资产 + 负债
Created with Highcharts 9.1.009-3006-3003-3112-3108016024084879093
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1692197.84万元,负债844156.58万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入13,087,153,128.587,993,043,517.913,776,851,559.4119,025,806,286.59
营业总成本12,617,293,868.827,789,522,484.273,678,286,988.7519,995,177,780.14
营业利润587,400,584.34317,343,745.9690,552,171.4-1,446,037,620.65
利润总额571,988,017.46293,797,312.0577,900,367.67-1,492,968,178.4
净利润554,495,769.58279,765,790.5860,176,209.17-1,516,427,334.32
其他综合收益3,086,398.37-40,712,722.89-52,610,170.5849,694,692.88
综合收益总额557,582,167.95239,053,067.697,566,038.59-1,466,732,641.44
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计9,115,407,832.648,897,743,168.889,357,175,806.528,960,844,383.94
非流动资产合计7,806,570,572.287,754,776,746.367,809,433,517.597,790,815,230.47
资产总计16,921,978,404.9216,652,519,915.2417,166,609,324.1116,751,659,614.41
流动负债合计6,162,799,255.86,364,536,497.27,095,293,961.897,087,194,350.58
非流动负债合计2,278,766,530.692,136,949,899.872,131,733,886.831,749,708,337.75
负债合计8,441,565,786.498,501,486,397.079,227,027,848.728,836,902,688.33
归属于母公司股东权益合计6,945,825,951.396,612,173,142.346,411,812,716.196,410,600,615.2
股东权益合计8,480,412,618.438,151,033,518.177,939,581,475.397,914,756,926.08
负债和股东权益合计16,921,978,404.9216,652,519,915.2417,166,609,324.1116,751,659,614.41
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计12,780,339,451.087,922,238,137.933,542,952,311.9520,096,758,837.73
经营活动现金流出小计10,634,872,485.637,148,900,307.653,876,802,981.3318,344,947,571.95
经营活动产生的现金流量净额2,145,466,965.45773,337,830.28-333,850,669.381,751,811,265.78
投资活动现金流入小计44,846,026.1421,066,274.913,796,062.92898,688,823.94
投资活动现金流出小计597,843,758.01533,411,507.31201,275,053.211,673,683,965.6
投资活动产生的现金流量净额-552,997,731.87-512,345,232.41-187,478,990.29-774,995,141.66
筹资活动现金流入小计3,763,906,836.891,631,983,246.961,251,700,0004,968,343,604.41
筹资活动现金流出小计4,546,799,823.711,862,277,469.62854,680,708.586,473,530,594.31
筹资活动产生的现金流量净额-782,892,986.82-230,294,222.66397,019,291.42-1,505,186,989.9
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额809,576,246.7630,698,375.21-124,310,368.25-528,370,865.78
期末现金及现金等价物余额3,482,161,346.182,703,283,474.632,548,274,731.172,672,585,099.42
TOP↑